Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2000 Apr;74(7):3427-9.
doi: 10.1128/jvi.74.7.3427-3429.2000.

Modulation of antigen-specific humoral responses in rhesus macaques by using cytokine cDNAs as DNA vaccine adjuvants

Affiliations

Modulation of antigen-specific humoral responses in rhesus macaques by using cytokine cDNAs as DNA vaccine adjuvants

J J Kim et al. J Virol. 2000 Apr.

Abstract

An important limitation of DNA immunization in nonhuman primates is the difficulty in generating high levels of antigen-specific antibody responses; strategies to enhance the level of immune responses to DNA immunization may be important in the further development of this vaccine strategy for humans. We approached this issue by testing the ability of molecular adjuvants to enhance the levels of immune responses generated by multicomponent DNA vaccines in rhesus macaques. Rhesus macaques were coimmunized intramuscularly with expression plasmids bearing genes encoding Th1 (interleukin 2 [IL-2] and gamma interferon)- or Th2 (IL-4)-type cytokines and DNA vaccine constructs encoding human immunodeficiency virus Env and Rev and simian immunodeficiency virus Gag and Pol proteins. We observed that the cytokine gene adjuvants (especially IL-2 and IL-4) significantly enhanced antigen-specific humoral immune responses in the rhesus macaque model. These results support the assumption that antigen-specific responses can be engineered to a higher and presumably more desirable level in rhesus macaques by genetic adjuvants.

PubMed Disclaimer

Figures

FIG. 1
FIG. 1
Modulation of antibody responses in rhesus macaques. Five groups of two rhesus macaques were immunized with 200 μg of each DNA vaccine construct at weeks 0, 6, and 12 and boosted with 500 μg of each DNA at week 28. Serum samples were collected from the immunized macaques at weeks 0, 18, and 36. Binding reactivities to recombinant HIV-1 gp120 envelope and SIV p27 Gag proteins (ImmunoDiagnostics, Inc., Bedford, Mass.) were determined by enzyme-linked immunosorbent assay as previously described (1). Specific binding (absorbance at 450 nm) was calculated by subtracting A450 values from serum samples bound to bovine serum albumin (control) from A450 values from serum samples bound to gp120, that is, the A450s of experimental wells minus the A450s of control wells. The endpoint antibody titers for immunized rhesus macaques were determined as previously described (1).

References

    1. Boyer J D, Ugen K E, Wang B, Agadjanyan M G, Gilbert L, Bagarazzi M, Chattergoon M, Frost P, Javadian A, Williams W V, Refaeli Y, Ciccarelli R B, McCallus D, Coney L, Weiner D B. Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination. Nat Med. 1997;3:526–532. - PubMed
    1. Chow Y-H, Huang W-L, Chi W-K, Chu Y-D, Tao M-H. Improvement of hepatitis B virus DNA vaccines by plasmids coexpressing hepatitis B surface antigen and interleuken-2. J Virol. 1997;71:169–178. - PMC - PubMed
    1. Hulskotte E G, Geretti A-M, Osterhaus A D. Towards an HIV-1 vaccine: lessons and studies in macaque models. Vaccine. 1998;97:904–915. - PubMed
    1. Iwasaki A, Stiernholm B J, Chan A K, Berstein N L, Barber B H. Enhanced CTL responses mediated by plasmid DNA immunogens encoding costimulatory molecules and cytokines. J Immunol. 1997;158:4591–4601. - PubMed
    1. Jiao S, Williams P, Berg R K, Hodgeman B A, Liu L, Repetto G, Wolff J A. Direct gene transfer into non-human primate myofibers in vivo. Hum Gene Ther. 1992;3:21–33. - PubMed

Publication types

LinkOut - more resources